Expression of cell surface markers after human B lymphocyte activation
- PMID: 6973760
- PMCID: PMC319670
- DOI: 10.1073/pnas.78.6.3848
Expression of cell surface markers after human B lymphocyte activation
Abstract
The fate of two recently described human B lymphocyte-specific antigens (B1 and B2) was studied after B-cell activation in vivo and in vitro. Whereas both B1 and B2 were present on virtually all B cells from normal lymph nodes, B2 was absent from approximately 50% of B cells from hyperplastic lymph nodes. When B cells from spleen, tonsil, or peripheral blood were stimulated in vitro with pokeweed mitogen, activated cells were found to lose B2 (days 4-5) and subsequently B1 (days 6-7). Temporally, B2 loss was accompanied by loss of surface IgD, expression of T10, and the development of intracytoplasmic IgM; B1 loss was correlated with the acquisition of surface IgG and the appearance of intracytoplasmic IgG. Peripheral blood B cells, on which B2 is normally only weakly expressed (B1++++B2+) in contrast to B cells from secondary lymphoid organs (B1++++B2++), exhibited a transitory increase in B2 expression to the B1++++B2++ phenotype prior to B2 disappearance during activation. Taken together with other findings, this observation suggests that peripheral blood may contain a relatively immature subpopulation of B cells.
Similar articles
-
Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets.J Immunol. 1985 Feb;134(2):820-7. J Immunol. 1985. PMID: 3917476
-
Production and secretion of immunoglobulins by in vitro-activated human B lymphocytes.Allergy. 1982 Apr;37(3):179-85. doi: 10.1111/j.1398-9995.1982.tb01894.x. Allergy. 1982. PMID: 6753627
-
Separation of human B lymphocytes on Helix pomatia A haemagglutinin into two major fractions differing in responsiveness to T-dependent mitogen (pokeweed mitogen) or antigen (tetanus toxoid).Scand J Immunol. 1986 Feb;23(2):143-52. doi: 10.1111/j.1365-3083.1986.tb01952.x. Scand J Immunol. 1986. PMID: 3081997
-
The human marginal zone B cell.Ann N Y Acad Sci. 2003 Apr;987:117-24. doi: 10.1111/j.1749-6632.2003.tb06039.x. Ann N Y Acad Sci. 2003. PMID: 12727630 Review.
-
Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs.Curr Opin Immunol. 1991 Apr;3(2):179-85. doi: 10.1016/0952-7915(91)90047-5. Curr Opin Immunol. 1991. PMID: 2069745 Review. No abstract available.
Cited by
-
Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19.J Exp Med. 1998 Jul 6;188(1):145-55. doi: 10.1084/jem.188.1.145. J Exp Med. 1998. PMID: 9653091 Free PMC article.
-
Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues.Am J Pathol. 1984 Mar;114(3):387-95. Am J Pathol. 1984. PMID: 6421166 Free PMC article.
-
Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.Degener Neurol Neuromuscul Dis. 2017 Feb 1;7:31-45. doi: 10.2147/DNND.S100096. eCollection 2017. Degener Neurol Neuromuscul Dis. 2017. PMID: 30050376 Free PMC article. Review.
-
The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia.Immunology. 1989 Nov;68(3):346-52. Immunology. 1989. PMID: 2531721 Free PMC article.
-
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.J Virol. 1993 Apr;67(4):2209-20. doi: 10.1128/JVI.67.4.2209-2220.1993. J Virol. 1993. PMID: 8383238 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials